Please login to the form below
Viral misinformation
This page shows the latest Viral misinformation news and features for those working in and with pharma, biotech and healthcare.
20/20 vision
Yet still people are seeing, hearing and believing ‘viral misinformation’ and, as a consequence, not getting their children vaccinated.
Latest news
-
UK no longer measles-free as vaccination rates fall dramatically
Experts have blamed the decrease in vaccination rates on ‘viral misinformation’, which has been exacerbated by the internet and social media platforms such as Twitter and Facebook. ... vaccine misinformation is addressed as effectively as possible”.
-
Growing vaccines scepticism poses global health risk
The rising levels of mistrust have a number of factors behind them, but ‘ viral misinformation’ enabled by the internet and social media is seen as the chief culprit. ... of the preventable deaths caused by their misinformation.
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Fake News is Bad for your Health
A recent article in Nature classed this as 'viral misinformation'. 1. ... Viral misinformation. Nature, 16 October 2018. http://www.nature.com/articles/d41586-018-07034-4?
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Pfizer reports positive results for elranatamab in multiple myeloma
- BMS presents positive four-year results for Opdivo combination in lung cancer
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- Merck sues US government over Medicare drug price negotiation programme
- How to Increase Engagement During Virtual Events
- AstraZeneca to stop post-marketing study of Andexxa following early success
- Janssen shares positive phase 3 results for erdafitinib in bladder cancer
- Generative AI is coming for healthcare
- Merck sues US government over Medicare drug price negotiation programme
- GSK’s RSV vaccine approved by European Commission for older adults
No results were found
PMHub
Springer Nature
Operating in 50+ countries, we’re a leading research, educational, and professional publisher dedicated to advancing scientific discovery. Whether you’re looking...
Latest intelligence
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
